KR840007006A - Method for preparing pyrazolo [4,3-b] [1,4] oxazine - Google Patents

Method for preparing pyrazolo [4,3-b] [1,4] oxazine Download PDF

Info

Publication number
KR840007006A
KR840007006A KR1019830005922A KR830005922A KR840007006A KR 840007006 A KR840007006 A KR 840007006A KR 1019830005922 A KR1019830005922 A KR 1019830005922A KR 830005922 A KR830005922 A KR 830005922A KR 840007006 A KR840007006 A KR 840007006A
Authority
KR
South Korea
Prior art keywords
carbon atoms
alkyl
aralkyl
sulfur
aryl
Prior art date
Application number
KR1019830005922A
Other languages
Korean (ko)
Inventor
프루흐트만(외 5) 로마니스
Original Assignee
베르네르 쇤, 하이레딘야 코비
트로폰 베르케 지엠비에이취 앤드캄파니 케이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르네르 쇤, 하이레딘야 코비, 트로폰 베르케 지엠비에이취 앤드캄파니 케이지 filed Critical 베르네르 쇤, 하이레딘야 코비
Publication of KR840007006A publication Critical patent/KR840007006A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용없음No content

Description

피라졸로[4,3-b] [1,4] 옥사진의 제조방법Method for preparing pyrazolo [4,3-b] [1,4] oxazine

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (10)

일반식(Ⅱ)의 화합물을 일반식(Ⅵ)의 N,N-디알킬아미드 및 포스포러스옥시클로라이드와 반응시키고 생성된 염을 -20˚C내지 100˚C의 온도에서 일반식(Ⅳ)의 하이드라진과 반응시키거나, 일반식(Ⅱ)의 옥사진을 일반식(Ⅶ)의 카복실산 에스테르와 아실화반응 시키고, 생성된 일반식(Ⅶ)의 아실 생성물을 황화시킨후 생성된 일반식(Ⅸ)의 티온을 -20내지 100˚C의 온도에서 일반식(Ⅳ)의 하이드라진과 반응시키는 것을 특징으로하여 일반식(Ⅰa)및 (Ⅰb)의 화합물을 제조하는 방법.The compound of formula (II) is reacted with N, N-dialkylamide and phosphorus oxychloride of formula (VI) and the resulting salt is reacted with the general formula (IV) at a temperature of -20 ° C to 100 ° C. After reacting with hydrazine or acylating an oxazine of general formula (II) with a carboxylic acid ester of general formula (II), and sulfiding the resulting acyl product of general formula (VII), Method for preparing compounds of formula (Ia) and (Ib), characterized in that the reaction of the thion with the hydrazine of the general formula (IV) at a temperature of -20 to 100 ° C. 상기 일반식에서In the above general formula R 및 R1은 동일 또는 상이할 수 있으며, 수소, 탄소수 1내지 18의 알킬 또는 페닐[이는 탄소수 1내지 6의 알킬, 탄소수 3내지 6의 사이클로알킬, 탄소수 7내지 22의 아르알킬, 탄소수 6내지 14의 아릴, 탄소수 1내지 12의 모노-및 디-알킬아미노, 탄소수 6내지 10의 아릴아미노, 탄소수 6내지 10의 아릴옥시, 탄소수1내지 12의 알킬티오, 탄소수 6내지 10의 아릴티오, 탄소수 7내지 22의 아르알콕시, 탄소수 7내지 16의 아르알킬아미노, 카르복실, 탄소수 2내지 13의 카르알콕시, 카바모일, 탄소수 1내지 12의 모노-및 디-알킬카바모일, 탄소수 1내지 12의 알킬설포닐, 탄소수 6내지 14의 아릴설포닐, 탄소수 12이하의 할로게노알킬(이는 불소, 염소, 브롬 및/요드에 의해 임의로 일-또는 다-치활된다), 탄소수 1내지 12의 하이드록시 알킬, 탄소수 1내지 12의 아미노알킬, 탄소수 3내지 13의 알콕시카보닐아미노알킬, 탄소수 12이하의 할로게노알콕시(이는 불소, 염소, 브롬 및/또는 요드에 의해 임의로 일-또는 다 치환된다), 할로겐(예 : 불소, 염소, 브롬 및 요드), 아미노, 탄소수 2내지 7의 아실아미노, 카바모일 아미노, 설포닐아미노, 하이드록실, 탄소수 2내지 7의 아실옥시, 설폰아미도, 니트로, 포르밀, 탄소수 2내지 13의 알킬카보닐, 탄소수 7내지 15의 아릴카보닐, 메틸렌카복실, 탄소수 3내지 8의 메틸렌 카복시알킬, 탄소수 4내지 9의 에틸렌 카복시알킬, 및 탄소수 5내지 10의 프로필렌 카복시알킬로 이루어진 그룹으로부터 선택된 5개 이하의 동일 또는 상이한 치환체에 의해 임의 치환된다]이고,R and R 1 may be the same or different and are hydrogen, alkyl of 1 to 18 carbon atoms or phenyl [which may be alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, aralkyl of 7 to 22 carbon atoms, 6 to 6 carbon atoms; Aryl of 14, mono- and di-alkylamino of 1 to 12 carbon atoms, arylamino of 6 to 10 carbon atoms, aryloxy of 6 to 10 carbon atoms, alkylthio of 1 to 12 carbon atoms, arylthio of 6 to 10 carbon atoms 7-22 aralkyl, aralkylamino having 7 to 16 carbon atoms, carboxyl, caralkoxy having 2 to 13 carbon atoms, carbamoyl, mono- and di-alkylcarbamoyl having 1 to 12 carbon atoms, alkyl having 1 to 12 carbon atoms Sulfonyl, arylsulfonyl having 6 to 14 carbon atoms, halogenoalkyl having 12 or less carbon atoms, which is optionally mono- or multi-reduced by fluorine, chlorine, bromine and / iodine, hydroxy alkyl having 1 to 12 carbon atoms, C1-C12 aminoalkyl, C3 Alkoxycarbonylaminoalkyl having 13 moieties, halogenoalkoxy having up to 12 carbon atoms, which is optionally mono- or polysubstituted by fluorine, chlorine, bromine and / or iodine, halogen (e.g. fluorine, chlorine, bromine and iodine) , Amino, acylamino of 2 to 7 carbon atoms, carbamoyl amino, sulfonylamino, hydroxyl, acyloxy of 2 to 7 carbon atoms, sulfonamido, nitro, formyl, alkylcarbonyl of 2 to 13 carbon atoms, 7 carbon atoms Up to 5 identical or different substituents selected from the group consisting of arylcarbonyl, methylene carboxyl, methylene carboxyalkyl having 3 to 8 carbon atoms, ethylene carboxyalkyl having 4 to 9 carbon atoms, and propylene carboxyalkyl having 5 to 10 carbon atoms; Optionally substituted by R2및 R3는 동일 또는 상이할 수 있으며, 수소 ; 또는 알킬기에 산소, 황 또는 질소가 하나 도는 여러개 삽입될 수 있는 탄소수 1내지 18의 알킬 ; 탄소수 2내지 12의 알케닐 도는 알키닐, 탄소수 7내지 12의 아릴알킬(여기에서 알케닐, 알키닐, 및 아르 알킬기에는 산소, 황 또는 질소가 하나 또는 여러개 삽입될 수 있다) 또는 탄소수 6내지 14의 아릴, 질소, 산소 및 황중에서 선택된 4개 이하의 로헤테 원자를 함유하는 5-내지 6-원헤테로 아릴, 알킬측쇄 중에 1내지 12개의 탄소원자를 함유하며, 질소, 산소 및 황중에서 선책된 4개 이하의 헤테로 원자를 함유하는 5-내지 6-원 헤테로 아릴알킬, 탄소수 2내지 13의 알킬카보닐, 탄소수 7내지 15의 아릴카보닐, 이는 탄소수 1내지 18의 알킬, 탄소수 3내지 6의 사이클로알킬, 탄소수 7내지 22의 아르알킬, 탄소수 9내지 14의 아릴, 탄소수 1내지 12의 모노-및 디-알킬아미노, 탄소수 6내지 10의 아릴아미노, 탄소수 6내지 10의 아릴옥시, 탄소수 1내지 12의 알킬티오, 탄소수 6내지 10의 아릴티오, 탄소수 7내지 22의 아르알콕시, 탄소수 7내지 16의 아르알킬 아미노, 카복실, 탄소수 2내지 13의 카브알콕시, 카바모일, 탄소수 1내지 12의 모노-및 디-알킬 카바모일, 탄소수 1내지 12의 알킬설포닐, 탄소수 6내지 14의 아릴설포닐, 탄소수 12이하의 할로게노알킬(이는 불소, 염소, 및/브롬또는 요드에 의해 임의로 일-또는 다-치환된다), 탄소수 1내지 12의 하이드록시알킬, 탄소수 1내지 12의 아미노알킬, 탄소수 3내지 13의 알콕시카보닐 아미노알킬, 탄소수 12이하의 할로게노알콕시(이는 불소, 염소, 브롬 또는/및 요드에 의해 임의로 일-또는 다-치환된다), 할로겐(예 : 불소, 염소, 브롬 또는/및 요드), 아미노, 탄소수 2내지 7의 아실아미노, 설폰 아미도, 니트로, 포르밀, 탄소수 2내지 18의 알킬카보닐, 탄소수 7내지 15의 아릴카보닐, 메틸렌카복실, 탄소수 3내지 8의 메틸렌카복시알킬, 탄소수 4내지 9의 에틸렌 카복시알킬 및 프로플렌 카복시알킬 중에서 선택된 5개 이하의 동일 또는 상이한 치환체를 임의로 함유할 수 있으며, 또는 질소, 산소 및 황중에서 선택된 4개 이하의 헤테로 원자를 함유하는 5-내지 6-의 헤테로 아릴 카보닐을 나타내고,R 2 and R 3 may be the same or different, hydrogen; Or alkyl having 1 to 18 carbons which may be inserted with one or more oxygen, sulfur or nitrogen in the alkyl group; Alkenyl or alkynyl having 2 to 12 carbon atoms, arylalkyl having 7 to 12 carbon atoms (wherein alkenyl, alkynyl, and aralkyl groups may contain one or several oxygen, sulfur or nitrogen) or 6 to 14 carbon atoms 5- to 6-membered heteroaryl containing up to 4 lohete atoms selected from aryl, nitrogen, oxygen and sulfur of 1 to 12 carbon atoms in the alkyl side chain, and 4 selected from nitrogen, oxygen and sulfur 5- to 6-membered heteroarylalkyl containing up to 8 heteroatoms, alkylcarbonyl having 2 to 13 carbon atoms, arylcarbonyl having 7 to 15 carbon atoms, which is alkyl having 1 to 18 carbon atoms and having 3 to 6 cyclo atoms Alkyl, aralkyl of 7 to 22 carbon atoms, aryl of 9 to 14 carbon atoms, mono- and di-alkylamino carbon atoms of 1 to 12 carbon atoms, arylamino of 6 to 10 carbon atoms, aryloxy of 6 to 10 carbon atoms, and 1 to 12 carbon atoms. Alkylthio, carbon number Arylthio of 6 to 10, aralkyl of 7 to 22 carbon atoms, aralkyl amino of 7 to 16 carbon atoms, carboxyl, carboalkoxy of 2 to 13 carbon atoms, carbamoyl, mono- and di-alkyl carbamoyl of 1 to 12 carbon atoms , Alkylsulfonyl having 1 to 12 carbon atoms, arylsulfonyl having 6 to 14 carbon atoms, halogenoalkyl having 12 or less carbon atoms, which is optionally mono- or multi-substituted by fluorine, chlorine, and / or bromine or iodine Hydroxyalkyl having 1 to 12, aminoalkyl having 1 to 12 carbon atoms, alkoxycarbonyl aminoalkyl having 3 to 13 carbon atoms, and halogenoalkoxy having 12 or less carbon atoms, which is optionally mono- by fluorine, chlorine, bromine or / and iodine Or poly-substituted), halogen (eg fluorine, chlorine, bromine or / and iodine), amino, acylamino of 2 to 7 carbon atoms, sulfone amido, nitro, formyl, alkylcarbonyl of 2 to 18 carbon atoms, C7-C15 arylcarbonyl, methylene carboxy May optionally contain up to 5 identical or different substituents selected from methylenecarboxyalkyl having 3 to 8 carbon atoms, ethylene carboxyalkyl having 4 to 9 carbon atoms and propene carboxyalkyl having 4 or 9 selected from nitrogen, oxygen and sulfur; 5- to 6-heteroaryl aryl carbonyl containing up to 2 hetero atoms; R5는 수소, 직쇄, 측쇄 또는 사이클릭알킬기, (각각은 1내지 6의개 의탄소원자를 함유하며, 하이드록실, 카복실, 포르밀, 아세틸, 알콕시, 알킬티오, 할로겐, 니트로, 치횐된 아미노그룹 도는 유리 아미노그룹에의해 임의 치횐될 수 있다)이거나 ; 질소, 산소 및 황 중에서 선책된 4개 이하의 헤테로 원자를 함유하고, 알킬 알콕시, 알킬티오 또는 할로겐에 의해 임의 치횐될 수 있는 방향족 또는 헤테로 방향 족 기이거나 ; 유사하게 치환된 아르알킬 또는 헤테로 알킬기이고,R 5 is hydrogen, a straight chain, branched or cyclic alkyl group (each containing 1 to 6 carbon atoms, each of which is hydroxyl, carboxyl, formyl, acetyl, alkoxy, alkylthio, halogen, nitro, substituted amino group or May be optionally substituted by free amino group); An aromatic or heteroaromatic group containing up to 4 heteroatoms selected from nitrogen, oxygen, and sulfur and optionally optionally substituted by alkyl alkoxy, alkylthio or halogen; Similarly substituted aralkyl or heteroalkyl group, 단, 일반식(IV)에서However, in general formula (IV) R3는 수소, 탄소수 1내지 18의 알킬, 탄소수 7내지 12의 아르알킬, 헤테로 알킬(여기에서 알킬, 아르알킬 및 헤테로 아르알킬기에는 산소, 황 및 질소가 하나 또는 여려개 삽입될 수 있음)이거나, 탄소수 6내지 10의 아릴 또는 헤테로 아릴 (여기에서 아릴 및 헤테로 아릴기는 알콕시, 알킬, 아르알킬, 사이클로알킬, 아릴, 알킬아미노, 디알킬아미노, 아릴아미노, 아릴옥시, 아릴티오, 알킬티오, 카복실, 카브알콕시, 시아노, 카바모일, 설포닐, 알킬설포닐, 할로게노알킬, 할로 게노알콕시, 할로겐, 아미노 및 치횐된 아미노, 설폰아미도메틸렌, 카복실, 메틸렌 카복시알킬 및 프로필렌카복시알킬 중에서 선택된 5이하의 동일 또는 상이한 치혼체에 의해 치횐될 수 있다)R 3 is hydrogen, alkyl of 1 to 18 carbon atoms, aralkyl of 7 to 12 carbon atoms, heteroalkyl, wherein one or several oxygen, sulfur and nitrogen may be inserted in the alkyl, aralkyl and hetero aralkyl group , Aryl or heteroaryl having 6 to 10 carbon atoms, wherein the aryl and heteroaryl groups are alkoxy, alkyl, aralkyl, cycloalkyl, aryl, alkylamino, dialkylamino, arylamino, aryloxy, arylthio, alkylthio, carboxyl 5 selected from carboalkoxy, cyano, carbamoyl, sulfonyl, alkylsulfonyl, halogenoalkyl, halogenoalkoxy, halogen, amino and substituted amino, sulfonamidomethylene, carboxyl, methylene carboxyalkyl and propylenecarboxyalkyl By the same or different tooth combinations below) ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: It is to be disclosed based on the initial application.
KR1019830005922A 1982-12-14 1983-12-14 Method for preparing pyrazolo [4,3-b] [1,4] oxazine KR840007006A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823246148 DE3246148A1 (en) 1982-12-14 1982-12-14 Pyrazolo[4,3-b][1,4]-oxazines, process for their preparation and their use as medicaments
DEP3246148.8 1982-12-14

Publications (1)

Publication Number Publication Date
KR840007006A true KR840007006A (en) 1984-12-04

Family

ID=6180567

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005922A KR840007006A (en) 1982-12-14 1983-12-14 Method for preparing pyrazolo [4,3-b] [1,4] oxazine

Country Status (4)

Country Link
JP (1) JPS59116288A (en)
KR (1) KR840007006A (en)
DE (1) DE3246148A1 (en)
ZA (1) ZA839258B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264685C (en) 1996-08-27 2002-10-15 Kyoji Noda 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
JO2998B1 (en) 2010-06-04 2016-09-05 Amgen Inc Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
CA2850166C (en) 2011-09-27 2019-12-03 Amgen Inc. Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
MX362896B (en) * 2013-02-19 2019-02-22 Amgen Inc Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer.
MX368703B (en) 2013-02-28 2019-10-11 Amgen Inc A benzoic acid derivative mdm2 inhibitor for the treatment of cancer.
WO2014151863A1 (en) 2013-03-14 2014-09-25 Amgen Inc. Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer
JOP20200296A1 (en) 2013-06-10 2017-06-16 Amgen Inc Processes of Making and Crystalline Forms of a MDM2 Inhibitor

Also Published As

Publication number Publication date
ZA839258B (en) 1984-08-29
JPS59116288A (en) 1984-07-05
DE3246148A1 (en) 1984-06-14

Similar Documents

Publication Publication Date Title
IE831005L (en) 4-phenyl-1, 3-dioxanes
US3809699A (en) Process for producing 6-amino-penicillanic acid
KR840007006A (en) Method for preparing pyrazolo [4,3-b] [1,4] oxazine
KR840001175A (en) Method for preparing [3H] -imidazo [5,1-d] -1,2,3,5-tetrazin-4-one derivative
SE7712630L (en) PROCEDURE FOR THE PREPARATION OF O-ALKYLATED HYDROXYLAMINES
IE41191B1 (en) Process for the manufacture of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide
ES425373A1 (en) Pyrazol-5-ones
KR840006487A (en) Method for preparing cephalosporin
ES8206462A1 (en) 2-Oxoazetidine derivatives and production thereof.
ES435754A1 (en) Procedure for the preparation of aromatic amidas of heterociclic compounds. (Machine-translation by Google Translate, not legally binding)
EP0028936A3 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
GB1147035A (en) Seed-treatment nematocides, and certain novel 2,4-dihalophenylsulphonates having nematocidal properties
SE7714407L (en) IMIDAZOLINES AND PROCEDURES FOR THE PREPARATION OF THEM
CA2295913A1 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
GB1385397A (en) Substituted ureas and their use as herbicides
KR890009879A (en) Method for preparing 5-amino-1-phenyl-4-nitropyrazole
KR930010038A (en) Method for preparing 5,7-diaryloxy-2- (2-heteroaryl) -triazolo [1,5-a] [1,3,5] triazine
US4072676A (en) Process for preparation of 6-aminopenicillanic acid derivatives
US3896110A (en) Process for preparation of 6-aminopenicillanic acid
KR840008025A (en) 5-imino-1,2-dithiol-one compound and its preparation
KR840004115A (en) Method for preparing cefuroxime derivative
KR920006305A (en) Chemical Synthesis of Oligonucleotides
ES453892A1 (en) Procedure for the preparation of 2-amino-quinazoline derivatives and their physiologically useful salts. (Machine-translation by Google Translate, not legally binding)
KR840001584A (en) Process for preparing cephalosporin compound
IE39408L (en) Methylsulphonyl-benzoic acid derivatives

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid